دورية أكاديمية

A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder.

التفاصيل البيبلوغرافية
العنوان: A case report of LAI two injection start in a 16-year-old adolescent with severe manic episode and comorbid cannabinoid use disorder.
المؤلفون: Orsolini L; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy. Electronic address: l.orsolini@staff.univpm.it., Biagiotti SP; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy., Martino LM; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy., Volpe U; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy.
المصدر: Asian journal of psychiatry [Asian J Psychiatr] 2024 Apr; Vol. 94, pp. 103992. Date of Electronic Publication: 2024 Mar 04.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101517820 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-2026 (Electronic) Linking ISSN: 18762018 NLM ISO Abbreviation: Asian J Psychiatr Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Amsterdam] : Elsevier
مواضيع طبية MeSH: Antipsychotic Agents*/therapeutic use , Bipolar Disorder*/drug therapy, Male ; Adolescent ; Humans ; Aripiprazole ; Mania/drug therapy ; Delayed-Action Preparations/therapeutic use
مستخلص: There is a lack of randomized clinical trials and few studies regarding long-acting injectable antipsychotics (LAIs) in adolescents. Non-adherence, aggressiveness, comorbid substance use disorder and lack of insight may represent the main reasons for starting LAIs. Hereby we describe a 16-year-old male adolescent subject with bipolar type I disorder and comorbid cannabinoid use disorder, successfully treated with two-injection start regimen of LAI aripiprazole. Two-injection start regime of aripiprazole could represent an effective and safe therapeutic option for adolescents with early onset bipolar disorder.
Competing Interests: Declaration of Competing Interest All authors do not have any competing interests to disclose.
(Copyright © 2024 Elsevier B.V. All rights reserved.)
فهرسة مساهمة: Keywords: Adolescent; Aripiprazole; Bipolar Disorder; LAI; Long-acting injectable aripiprazole; Two-injection start aripiprazole
المشرفين على المادة: 82VFR53I78 (Aripiprazole)
0 (Delayed-Action Preparations)
0 (Antipsychotic Agents)
تواريخ الأحداث: Date Created: 20240310 Date Completed: 20240401 Latest Revision: 20240401
رمز التحديث: 20240401
DOI: 10.1016/j.ajp.2024.103992
PMID: 38461611
قاعدة البيانات: MEDLINE
الوصف
تدمد:1876-2026
DOI:10.1016/j.ajp.2024.103992